ORCL
Oracle Corporation
Quarterly revenue, EPS, free cash flow, valuation, and Rule of 40 scores for Oracle Corporation.
Coverage
Earnings release dates
| Quarter | End date | Publication date | Release |
|---|---|---|---|
| 2027 Q1 | 2026-08-31 | 2026-09-09 | Details → |
| 2026 Q4 | 2026-05-31 | 2026-06-10 | Details → |
| 2026 Q3 | 2026-02-28 | 2026-03-11 | Details → |
| 2026 Q2 | 2025-11-30 | 2025-12-09 | Details → |
| 2026 Q1 | 2025-08-31 | 2025-09-09 | Details → |
| 2025 Q4 | 2025-05-31 | 2025-06-10 | Details → |
| 2025 Q3 | 2025-02-28 | 2025-03-10 | Details → |
| 2025 Q2 | 2024-11-30 | 2024-12-09 | Details → |
| 2025 Q1 | 2024-08-31 | 2024-09-09 | Details → |
Company History
Larry Ellison and team launch company focused on relational databases, pioneering commercial SQL implementation and setting stage for enterprise dominance.
Public listing provides capital surge during early database boom, fueling rapid expansion and establishing Oracle as a tech growth stock.
$10.3B takeover expands enterprise applications suite amid consolidation wave, shifting narrative to aggressive M&A growth strategy.
$7.4B deal brings Java, hardware engineering, and open-source assets; marks entry into integrated hardware-software but initially weighs on margins.
$9.3B purchase accelerates cloud ERP transition, signaling pivot from on-premise legacy to SaaS amid slowing traditional revenue.
$28B healthcare IT deal diversifies into verticals, but integration challenges and debt highlight risks in late-stage M&A era.
Major deals (e.g., with Nvidia, OpenAI potential) and OCI growth ignite stock rally, reframing Oracle as viable hyperscaler challenger.
Record cloud revenue growth and backlog push shares to all-time highs (~$300+), validating multi-year turnaround but raising capex sustainability questions.
